Friday, March 06, 2020

Research shows how physical cues drive cell migration, cancer metastasis, and treatment

Cancer cells are a product of their environment. The surrounding cells, extracellular matrix, and other features influence disease progression and spread of cancer cells to other parts of the body. Chemical cues like the presence of nutrients and oxygen have been studied for decades, but more recently, researchers have turned their attention to equally important physical cues.

New research on the tumor mechanical microenvironment will be presented at the 2020 American Physical Society March Meeting in Denver. Highlights include a study that looks at how the anisotropy of the extracellular matrix affects cancer cell migration, a novel optical tweezer-based tool that probes mechanical cues, and a model to find the best place within a tumor to inject a chemotherapy drug.


Mechanical cues drive metastasis

Oregon State University researcher Bo Sun will present his findings on the complex interactions between cancer cell migration and the extracellular matrix, a 3D network of collagen, proteins, and other molecules that support the surrounding cells. Specifically, he will discuss the anisotropy of the extracellular matrix, and how a particular alignment of collagen fibers can create a cancer cell superhighway of sorts.

For most research in the field so far, a dominant paradigm is that rigidity of the tissue environment is the dominant factor that guides cell migration. The cell wants to move to a more rigid region compared to a soft region. We're seeing that a different type of physical property, anisotropy of the environment, is more efficient in terms of guiding cell migration."    Bo Sun, Oregon State University researcher

For instance, collagen fibers aligned circumferentially around the tumor causes the cancer cells to become trapped by this alignment, whereas fibers arranged radially provide a frictionless highway for cells to migrate outward. Studying the way cells move in their environment--and what factors drive that movement--has implications for understanding how cancer cells infiltrate new areas of the body.


Probing tissues with optical tweezers

Biophysicist Kandice Tanner has repurposed a tool to measure the mechanical cues that may influence how tumor cells disseminate to different organs. The optical tweezer-based technique can probe the physical properties of cells in living animals with microscale resolution.

"Previously, characterization of mechanical properties of tissues, cells, and extracellular matrix hydrogels were mainly obtained using bulk rheological or nanometer scale techniques such as atomic force microscopy and primarily for in vitro systems," said Tanner, an investigator at the National Cancer Institute, part of the National Institutes of Health. "These techniques are useful to assess material properties but do not possess the resolution that is needed to resolve length scales that are compatible with the micron-size protrusions used by cells to respond to external cues."

Tanner and her colleagues employed the technique to measure the viscoelastic properties of tissue in living zebrafish and 3D culture models of breast cancer progression. For the latter project, they used optical trap-based active microrheology to map internal cellular and external extracellular matrix mechanics with near simultaneity. They found that, unlike healthy cells, breast tumor cells do not match their mechanical properties to the surrounding microenvironment.


As cancer cells migrate from their original primary tumor, they encounter many physical cues before establishing new lesions in different organs such as the patient's bones, brain, liver, or lungs," said Tanner. "We believe that by decoding the role of the physical cues, we can understand why some tumor cells are able to colonize one organ versus the other."


Shapeshifting cells

While the extracellular matrix simulated in lab experiments is almost purely elastic--it bounces back to its original form once a stress is removed--the scaffolding in the brain, liver, and other tissues is not. In these regions, the extracellular matrix exhibits both viscous and elastic characteristics. Harvard researcher Anupam Gupta will present his research on how viscoelastic properties of the extracellular matrix can transform normal cells into cancer cells.

Gupta and his colleagues have observed that increasing the fluidic nature of the extracellular matrix causes normal breast cells to lose their spherical shape, form a rough interface, and develop fingers. Based on these results, they created a mathematical model of the cell mechanics that shows finger formation stops with increasing viscosity or elasticity.


Modeling cancer drug response

Cancer treatment relies heavily on trial and error, which can lead to unnecessary toxicity and cost. Models that predict how a cancer drug will diffuse throughout the tumor offer a possible solution for oncologists. Aminur Rahman develops these kinds of mechanistic models of drug response as a method for oncologists to choose the most effective treatment before administering any medication.

"Our mechanistic models are able to produce dose-response curves that oncologists would see from cell line and drug data pairs," said Rahman, a post-doctoral researcher at Texas Tech University. "We realized that perhaps this research could be used for computer-aided treatment strategies."

He will present the results of multiple projects in a poster presentation. The first investigates a model of drug distribution after injection directly into a solid tumor and its effect on cancer cell death. While the model assumes the tumor is spherical and homogeneous, brain tumors in particular tend to be highly inhomogeneous and anisotropic. The second study develops a more sophisticated computational model for inhomogeneous-anisotropic drug diffusion using real-world diffusion tensor MRI data.

"Because of the tumor's inhomogeneity and anisotropy, the center might not be the best place to inject drugs," said Rahman. "We looked at different injection sites, and it was not necessary the center that would do the trick. In such cases, having a model would help an oncologist know where to inject the drug."


This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
 

Labels: , , , , , ,

Sunday, July 07, 2019

Immune-boosting compound extends survival of pancreatic cancer in mice

Researchers have found a chemical compound that promotes a vigorous immune assault against pancreatic cancer.

The chemical compound extends survival by months in mice. The findings suggested a way to improve immunotherapy for the deadly disease in patients.

The researchers identified a compound, called ADH-503, that interferes with the migration of myeloid cells. Normally, pancreatic tumors are teeming with myeloid cells that suppress the immune response.

When the researchers gave the compound to mice with pancreatic cancer, the number of myeloid cells in and near the tumors dropped, and the remaining myeloid cells were of the kind that promoted, rather than suppressed, immune responses.

This environment translated into greater numbers of cancer-killing T cells in the tumor, significantly slower tumor growth and longer survival.

Then, the researchers investigated whether creating this same environment could make pancreatic tumors susceptible to standard immunotherapy. First, they treated mice with a so-called PD-1 inhibitor, a standard immunotherapy used to treat other kinds of cancer.

Unsurprisingly, they saw no effect. But when the researchers gave the mice the immunotherapy in conjunction with ADH-503, the tumors shrank and the mice survived significantly longer.

In some experiments, all the tumors disappeared within a month of treatment, and all the mice survived for four months, when the researchers stopped monitoring them. In comparison, all the untreated mice died within six weeks.

"Pancreatic cancer is a highly lethal disease, and we are in desperate need of new therapeutic approaches," said  an associate professor of medicine and of pathology and immunology. "In animal studies, this small molecule led to very marked improvements and was even curative in some cases. We are hopeful that this approach could help pancreatic cancer patients."

While pancreatic cancer is the third leading cause of cancer-related death in the United States, only about three percent of clinical trials for cancer immunotherapies target pancreatic cancer.

"You can't make a one-to-one translation between animal studies and people, but this is very encouraging,"the author said. "More study is needed to understand if the compound is safe and effective in people."

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.                                    PS- THOSE INTERESTED IN RECIPES ARE FREE TO  VIEW MY BLOG-                                                                                           https://gseasyrecipes.blogspot.com/                                                                                                                                                FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                  https:// kneereplacement-stickclub.blogspot.com/                                                                      FOR CROCHET DESIGNS                                                                                                                                                                                     https://gscrochetdesigns.blogspot.com

Labels: , , , , , , , , , ,

Wednesday, February 13, 2019

'Pied Piper' Device That Lures Tumors From The Brain Awarded Breakthrough Status By FDA

Brain tumors are notoriously difficult to treat, often growing quickly and spreading through the brain. But what if we could trick the cancerous cells to proliferate in a new direction, essentially luring them out of the brain and outside the skull? Well, researchers are attempting to do just that, and their work has been awarded “ breakthrough status” by the government.

Called the Tumor Monorail, the device has been described as a “pied piper”, thanks to its ability to trick and lure cells away from a tumor, just as the Pied Piper lured rats, and then children, away from the town of Hamelin in the well-known fairy tale.

The Tumor Monorail is essentially a long, thin tube with a small reservoir at one end. The reservoir sits on top of the skull, just under the scalp, and tricks tumor cells into migrating up the tube and out of the brain where they can be removed by a surgeon. It does this by mimicking the brain’s white matter, where the tumor would normally grow. The cancerous cells spread up the tube, thinking they are growing further into the brain and expanding the tumor. Gotcha.

So far, the Tumor Monorail has only been tested successfully in rats. The researchers now need to work on testing its safety and efficacy in humans. That’s why its new breakthrough status is so important. Developing new treatments and proving they are fit for clinical use is a long, ardous process, but the FDA breakthrough initiative helps to fast-track the development and review of new treatments for serious or life-threatening illnesses.

Glioblastoma – an aggressive type of brain tumor with a poor survival rate – is one of these conditions. Innovative new ways to tackle it, like the Tumor Monorail, could have a hugely positive impact, so speeding up its development is key. Still, it’s important to note that the new allocation doesn’t mean the device has been approved for clinical use by the FDA. The researchers behind it will have to prove it's both safe and effective in people first.

“The tumor monorail device is a true game-changer in how we think about treating brain tumors,” said  a neurosurgeon in a statement. “There are many tumors that are considered inoperable due to the location of the tumor or the frailty of the patient. This device affords clinicians the ability to surgically treat these tumors with a minimal approach.”

Back in 2014, the researchers successfully managed to get their device to work in rats. The rats’ brain tumors shrank by more than 90 percent and spread more slowly. Since then, the researchers have tweaked the device, and repeatedly shown its effectiveness in rats.

“This was the first demonstration that you can engineer migration inside the body and move a tumor from point A to point B by design,” explained  one of the researcher. “It was also the first demonstration of bringing the tumor to your drug rather than your drug going into the brain and killing valuable cells.”

Five years on and the device has breakthrough status. “The most exciting part about this designation is that it gives us the opportunity to look at the FDA as a partner rather than a reviewer,” said project leader. “With direct access to the FDA reviewers, we can get more efficient, faster feedback on our experimental ideas to make sure we’re addressing all of their concerns from the very start.”

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.                                    PS- THOSE INTERESTED IN RECIPES ARE FREE TO  VIEW MY BLOG-                                                                                           https://gseasyrecipes.blogspot.com/       

                                                                                                                                                                    FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                  https:// kneereplacement-stickclub.blogspot.com/           
                                                                           FOR CROCHET DESIGNS                                                                                                                                                                                                  https://gscrochetdesigns.blogspot.com

Labels: , , , , , , , , , , , , , , ,